We are live on
!
Find out more
FAS
Formuepleje A/S Portfolio holdings
AUM
$1.28B
1-Year Est. Return
24.24%
This Fund
S&P 500
This Quarter
Est. Return
+12.81%
1 Year Est. Return
+24.24%
3 Year Est. Return
+75.12%
5 Year Est. Return
+78.91%
10 Year Est. Return
+321.64%
AUM
$1.41B
AUM Growth
+$333M
(+31%)
Cap. Flow
+$180M
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
39.81%
Holding
94
New
19
Increased
21
Reduced
48
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$25.1M |
| 2 |
MSCI
MSCI
|
+$24.5M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$16.1M |
| 4 |
ICICI Bank
IBN
|
+$13.4M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$12.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$16.1M |
| 2 |
Deere & Co
DE
|
+$13.3M |
| 3 |
Cooper Companies
COO
|
+$12.7M |
| 4 |
United Rentals
URI
|
+$8.08M |
| 5 |
Edwards Lifesciences
EW
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.15% |
| 2 | Financials | 21.62% |
| 3 | Healthcare | 17.73% |
| 4 | Industrials | 15.29% |
| 5 | Consumer Discretionary | 5.6% |
Similar funds
UFM
AWAG
MTC
SP
IWA
SFM
AHC
FG
Formuepleje A/S's Q4 2023 Portfolio in Review
As of Q4 2023, Formuepleje A/S held 94 positions worth $1.41B, up 31% from $1.08B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Formuepleje A/S deployed $180M of net new capital in Q4 2023, opening 19 new positions and adding to 21 existing holdings. Its largest new stake was Marsh: 129,996 shares worth $24.6M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Deere & Co, an estimated $13.3M trimmed.
- Formuepleje A/S's largest Q4 2023 buy was Marsh: 129,996 shares worth $24.6M.
- Formuepleje A/S added most to MSCI in Q4 2023, an estimated $24.5M increase.
- Formuepleje A/S's biggest Q4 2023 reduction was Deere & Co, cutting an estimated $13.3M.
- Formuepleje A/S fully exited Vertex Pharmaceuticals in Q4 2023, selling an estimated $16.1M.
- Formuepleje A/S's ten largest holdings make up 40% of its $1.41B portfolio in Q4 2023.
- Formuepleje A/S opened 19 new positions and closed 6 in Q4 2023.
- Formuepleje A/S's portfolio value rose 31% quarter-over-quarter to $1.41B.
Based on Formuepleje A/S's 13F filing for Q4 2023, filed 27 Aug 2026.